Gary Nabel
Directeur/Membre du Conseil chez SIGA TECHNOLOGIES, INC.
Fortune : 25 M $ au 30/04/2024
Profil
Gary J.
Nabel was the founder of ModeX Therapeutics, Inc. founded in 2020, where he held the position of President & Chief Executive Officer until 2022.
Currently, he holds three positions as an Independent Director at SIGA Technologies, Inc. since 2021, as Director & Chief Innovation Officer at OPKO Health, Inc. since 2022, and as an Independent Director at Candel Therapeutics, Inc. since 2022.
Previously, he served as Chairman at Keystone Symposia, Director-Vaccine Research Center at National Institutes of Health from 1999 to 2012, and as Chief Scientific Officer & Senior Vice President at Sanofi from 2014 to 2020.
Dr. Nabel received his doctorate degree from Harvard University in 1980 and his undergraduate degree from Harvard College in 1975.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
OPKO HEALTH, INC.
2,95% | 29/02/2024 | 20 526 980 ( 2,95% ) | 25 M $ | 30/04/2024 |
SIGA TECHNOLOGIES INC
0,04% | 19/04/2024 | 26 216 ( 0,04% ) | 226 506 $ | 30/04/2024 |
| 01/04/2024 | 0 ( -.--% ) | - $ | 30/04/2024 |
Postes actifs de Gary Nabel
| Sociétés | Poste | Début |
|---|---|---|
| SIGA TECHNOLOGIES, INC. | Directeur/Membre du Conseil | 15/06/2021 |
| OPKO HEALTH, INC. | Directeur/Membre du Conseil | 09/05/2022 |
| CANDEL THERAPEUTICS, INC. | Directeur/Membre du Conseil | 08/08/2022 |
Anciens postes connus de Gary Nabel
| Sociétés | Poste | Fin |
|---|---|---|
Modex Therapeutics, Inc.
 Modex Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of OPKO Health, Inc., ModeX Therapeutics, Inc. is a biotechnology research company focused on developing multi-specific immune therapies for cancer and infectious diseases. The private company is based in Natick, MA. The company was founded in 2020 by Elias A. Zerhouni, Gary J. Nabel, Alexis A. Borisy. ModeX Therapeutics was acquired by OPKO Health, Inc. on May 09, 2022 for $300 million. | Directeur Général | 01/05/2022 |
| SANOFI | Directeur Technique/Scientifique/R&D | 01/11/2020 |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | 01/01/2012 |
Keystone Symposia
 Keystone Symposia Miscellaneous Commercial ServicesCommercial Services Keystone Symposia operates as a catalyst for the advancement of biomedical and life sciences by connecting scientists within and across disciplines at conferences and workshops. The company was founded by C. Fred Fox in 1972 and is headquartered in Silverthorne, CO. | Président | - |
Formation de Gary Nabel
| Harvard University | Doctorate Degree |
| Harvard College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| SANOFI | Commercial Services |
| SIGA TECHNOLOGIES, INC. | Health Technology |
| OPKO HEALTH, INC. | Health Services |
| CANDEL THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Keystone Symposia
Keystone Symposia Miscellaneous Commercial ServicesCommercial Services Keystone Symposia operates as a catalyst for the advancement of biomedical and life sciences by connecting scientists within and across disciplines at conferences and workshops. The company was founded by C. Fred Fox in 1972 and is headquartered in Silverthorne, CO. | Commercial Services |
Modex Therapeutics, Inc.
Modex Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of OPKO Health, Inc., ModeX Therapeutics, Inc. is a biotechnology research company focused on developing multi-specific immune therapies for cancer and infectious diseases. The private company is based in Natick, MA. The company was founded in 2020 by Elias A. Zerhouni, Gary J. Nabel, Alexis A. Borisy. ModeX Therapeutics was acquired by OPKO Health, Inc. on May 09, 2022 for $300 million. | Commercial Services |
National Institutes of Health
National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Government |
